Human Genome Epidemiology Literature Finder
|
Records 1 - 26 (of 26 Records) |
| Query Trace: Hepatitis B and HCCS[original query] |
|---|
| Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002 Oct 11 (10 Pt 1): 1126-9. Qian Geng-Sun, Kuang Shuang-Yuan, He Xia, Groopman John D, Jackson Peta |
| PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology (Baltimore, Md.) 2003 Nov 38 (5): 1242-9. Okamoto Hiroyuki, Yasui Kohichiroh, Zhao Chen, Arii Shigeki, Inazawa Joh |
| Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. International journal of cancer. Journal international du cancer 2007 Apr 120 (8): 1610-7. Yeh Shiou-Hwei, Chiu Chi-Ming, Chen Chi-Ling, Lu Shu-Fen, Hsu Hey-Chi, Chen Ding-Shinn, Chen Pei-J |
| Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 2011 Aug 31 (7): 1006-12. Eurich Dennis, Boas-Knoop Sabine, Morawietz Lars, Neuhaus Ruth, Somasundaram Rajan, Ruehl Martin, Neumann Ulf P, Neuhaus Peter, Bahra Marcus, Seehofer Dani |
| TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia. Carcinogenesis 2012 Jun 33 (6): 1219-24. Gouas Doriane A, Villar Stphanie, Ortiz-Cuaran Sandra, Legros Pénélope, Ferro Gilles, Kirk Gregory D, Lesi Olufunmilayo A, Mendy Maimuna, Bah Ebrima, Friesen Marlin D, Groopman John, Chemin Isabelle, Hainaut Pier |
| Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy. Transplantation 2012 Mar 93 (6): 644-9. Eurich Dennis, Boas-Knoop Sabine, Bahra Marcus, Neuhaus Ruth, Somasundaram Rajan, Neuhaus Peter, Neumann Ulf, Seehofer Dani |
| Correlation of TP53 mutations with HCV positivity in hepatocarcinogenesis: identification of a novel TP53 microindel in hepatocellular carcinoma with HCV infection. Oncology reports 2013 Jul 30 (1): 119-24. Long Jiang, Wang Yan, Li Man, Tong Wei-Min, Jia Ji-Dong, Huang Ji |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics 2013 Aug 102 (2): 74-83. Tornesello Maria Lina, Buonaguro Luigi, Tatangelo Fabiana, Botti Gerardo, Izzo Francesco, Buonaguro Franco |
| TERT promoter mutation in resectable hepatocellular carcinomas: a strong association with hepatitis C infection and absence of hepatitis B infection. International journal of surgery (London, England) 2014 12 (7): 659-65. Chen Yu-Ling, Jeng Yung-Ming, Chang Chih-Ning, Lee Hsin-Jung, Hsu Hey-Chi, Lai Po-Lin, Yuan Ray-Hwa |
| Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas. Journal of gastroenterology and hepatology 2015 Sep 30 (9): 1397-404. Su Yu-Hung, Ng Kwai-Fong, Yu Ming-Chin, Wu Ting-Jung, Yeh Ta-Sen, Lee Wei-Chen, Lin Yong-Shiang, Hsieh Tsung-Han, Lin Chun-Yen, Yeh Chau-Ting, Chen Tse-Chi |
| Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. Nature communications 2015 6 6120. Fujimoto Akihiro, Furuta Mayuko, Shiraishi Yuichi, Gotoh Kunihito, Kawakami Yoshiiku, Arihiro Koji, Nakamura Toru, Ueno Masaki, Ariizumi Shun-ichi, Nguyen Ha Hai, Shigemizu Daichi, Abe Tetsuo, Boroevich Keith A, Nakano Kaoru, Sasaki Aya, Kitada Rina, Maejima Kazihiro, Yamamoto Yujiro, Tanaka Hiroko, Shibuya Tetsuo, Shibata Tatsuhiro, Ojima Hidenori, Shimada Kazuaki, Hayami Shinya, Shigekawa Yoshinobu, Aikata Hiroshi, Ohdan Hideki, Marubashi Shigeru, Yamada Terumasa, Kubo Michiaki, Hirano Satoshi, Ishikawa Osamu, Yamamoto Masakazu, Yamaue Hiroki, Chayama Kazuaki, Miyano Satoru, Tsunoda Tatsuhiko, Nakagawa Hidewa |
| Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 2016 Jun . Pezzuto Francesca, Izzo Francesco, Buonaguro Luigi, Annunziata Clorinda, Tatangelo Fabiana, Botti Gerardo, Buonaguro Franco M, Tornesello Maria Li |
Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
Cancer 2017 Jun . Lin You-Yu, Yu Ming-Whei, Lin Shi-Ming, Lee Shou-Dong, Chen Chih-Ling, Chen Ding-Shinn, Chen Pei-J |
| Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Microbial pathogenesis 2017 May . Jiao Fengping, Long Lu, Ding Shanlong, Xie Xiaomeng, Jia Le, Lu Fengm |
| Association between Hepatitis C Virus Infection, p53 Phenotypes, and Gene Variants of Adenomatous Polyposis Coli in Hepatocellular Carcinomas. Journal of digestive diseases and hepatology 2016 2016 (5): . Council Leona N, Shanmugam Chandrakumar, Suswam Esther A, Katkoori Venkat R, Heslin Martine J, Hanna Alex, Jhala Nirag C, Varambally Sooryanarayana, Manne Upend |
| Genetic Polymorphisms of Fas/FasL Promoter Associated with Hepatitis C cirrhosis and HCC. Asian Pacific journal of cancer prevention : APJCP 2017 10 18 (10): 2683-2688. Abed Sally, El-Dosoky Mohamed, El Sayed Zaki Maysaa, EL-Shafey Moham |
| Clinicopathologic characteristics of Wnt/?-catenin-deregulated hepatocellular carcinoma. Indian journal of cancer 2018 8 54 (4): 634-639. Verma Anuj, Bal Munita, Ramadwar Mukta, Deodhar Kedar, Patil Prachi, Goel Mahe |
| Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology (Baltimore, Md.) 2018 Aug . Li Chiao-Ling, Li Chen-Yu, Lin You-Yu, Ho Ming-Chih, Chen Ding-Shinn, Chen Pei-Jer, Yeh Shiou-Hw |
| Telomerase reverse transcriptase mutations in plasma DNA in patients with hepatocellular carcinoma or cirrhosis: Prevalence and risk factors. Hepatology communications 2018 Jun 2 (6): 718-731. Jiao Jingjing, Watt Gordon P, Stevenson Heather L, Calderone Tiffany L, Fisher-Hoch Susan P, Ye Yuanqing, Wu Xifeng, Vierling John M, Beretta Lau |
| Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 May . Liu Wenbin, Wu Jianfeng, Yang Fan, Ma Longteng, Ni Chong, Hou Xiaomei, Wang Ling, Xu Aijing, Song Jiahui, Deng Yang, Xian Linfeng, Li Zixiong, Wang Shuo, Chen Xi, Yin Jianhua, Han Xue, Li Chengzhong, Zhao Jun, Cao Guangw |
| Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection. Infectious agents and cancer 2020 6 15 37. Javanmard Davod, Najafi Mohammad, Babaei Mohammad Reza, Karbalaie Niya Mohammad Hadi, Esghaei Maryam, Panahi Mahshid, Safarnezhad Tameshkel Fahimeh, Tavakoli Ahmad, Jazayeri Seyed Mohammad, Ghaffari Hadi, Ataei-Pirkooh Angila, Monavari Seyed Hamidreaz, Bokharaei-Salim Far |
| Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: A cross-sectional study (2016-2017). Health science reports 2020 5 3 (2): e155. Alvarez Christian S, Ortiz Jeremy, Bendfeldt-Avila Giovanna, Xie Yi, Wang Mingyi, Wu Dongjing, Higson Herbert, Lee Elisa, Teshome Kedest, Barnoya Joaquin, Kleiner David E, Groopman John D, Orozco Roberto, McGlynn Katherine A, Gharzouzi Eduardo, Dean Micha |
| Hepatocellular carcinoma after a sustained virological response by direct-acting antivirals harbors TP53 inactivation. Cancer medicine 2022 2 11 (8): 1769-1786. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Kakuda Yuko, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Overview and clinical significance of multiple mutations in individual genes in hepatocellular carcinoma. BMC cancer 2022 Oct 22 (1): 1046. Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Ito Takaaki, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Otsuka Shimpei, Ohnami Sumiko, Nagashima Takeshi, Hatakeyama Keiichi, Sugino Takashi, Urakami Kenichi, Akiyama Yasuto, Yamaguchi K |
| Preliminary radiogenomic study of hepatitis B virus-related hepatocellular carcinoma: associations between MRI features and mutations. Personalized medicine 2023 5 . Shanshan Gao, Feihang Wang, Wei Sun, Xianling Qian, Yuan Ji, Yunfeng Cheng, Xiaolin Wang, Lingxiao Liu, Ruofan Sheng, Mengsu Ze |
| Leptin receptor Gln223Arg and Lys109Arg polymorphisms may be associated with HBV-related hepatocellular carcinoma risk: A system review and meta-analysis. Environmental toxicology 2024 4 . Xiaofeng Dong, Mengjie Zou, Chunxing Li, Honglin Luo, Shaoliang Zhu, Zheng Go |
- Page last reviewed:Feb 1, 2024
- Content source: